Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
dostarlimab | 1.91 | 1 | 3214 | 13 |
dostarlimab fda approval | 1.74 | 0.6 | 7241 | 19 |
dostarlimab-gxly | 1.23 | 0.2 | 6101 | 99 |
dostarlimab rectal cancer | 1.03 | 1 | 8899 | 2 |
dostarlimab package insert | 1.43 | 0.2 | 1462 | 50 |
dostarlimab gsk | 1.55 | 0.1 | 5358 | 81 |
dostarlimab price | 0.01 | 0.8 | 9732 | 68 |
dostarlimab smpc | 1.07 | 0.6 | 2354 | 24 |
dostarlimab endometrial cancer | 1.35 | 0.5 | 4400 | 75 |
dostarlimab jemperli | 0.37 | 0.3 | 4497 | 71 |
dostarlimab spc | 0.06 | 1 | 4476 | 35 |
dostarlimab ema | 0.89 | 0.9 | 3350 | 37 |
dostarlimab side effects | 0.28 | 0.7 | 5783 | 67 |
dostarlimab vs pembrolizumab | 1 | 1 | 4504 | 58 |
dostarlimab moa | 1.39 | 0.2 | 4619 | 85 |
dostarlimab drug | 1.53 | 0.5 | 4408 | 22 |
dostarlimab uspi | 1.6 | 0.6 | 2291 | 22 |
dostarlimab fda | 0.2 | 0.4 | 8387 | 62 |
dostarlimab mechanism of action | 0.99 | 0.3 | 600 | 4 |
dostarlimab immunotherapy | 0.12 | 0.3 | 8672 | 19 |
dostarlimab fda label | 1.21 | 0.9 | 6031 | 21 |
dostarlimab fachinfo | 0.03 | 0.9 | 4135 | 63 |
dostarlimab colon cancer | 1.85 | 0.1 | 2994 | 93 |
dostarlimab chpl | 1.23 | 1 | 1533 | 16 |